PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.05%
Revenue growth under 50% of AVGO's 6.05%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.38%
Gross profit growth under 50% of AVGO's 12.78%. Michael Burry would be concerned about a severe competitive disadvantage.
8.35%
EBIT growth below 50% of AVGO's 71.91%. Michael Burry would suspect deeper competitive or cost structure issues.
8.35%
Operating income growth under 50% of AVGO's 71.91%. Michael Burry would be concerned about deeper cost or sales issues.
11.66%
Net income growth under 50% of AVGO's 78.75%. Michael Burry would suspect the firm is falling well behind a key competitor.
10.00%
EPS growth under 50% of AVGO's 75.82%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
12.82%
Diluted EPS growth under 50% of AVGO's 78.57%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.66%
Share reduction while AVGO is at 4.15%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.29%
Reduced diluted shares while AVGO is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.98%
Dividend growth under 50% of AVGO's 7.09%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
105.33%
Positive OCF growth while AVGO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
134.07%
FCF growth above 1.5x AVGO's 7.21%. David Dodd would verify if the firm’s strategic investments yield superior returns.
115.98%
10Y revenue/share CAGR at 50-75% of AVGO's 219.16%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
30.54%
5Y revenue/share CAGR under 50% of AVGO's 182.05%. Michael Burry would suspect a significant competitive gap or product weakness.
47.41%
3Y revenue/share CAGR under 50% of AVGO's 165.37%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
336.77%
10Y OCF/share CAGR 1.25-1.5x AVGO's 295.84%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
555.72%
5Y OCF/share CAGR above 1.5x AVGO's 135.16%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
21.18%
3Y OCF/share CAGR under 50% of AVGO's 141.27%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
293.57%
Below 50% of AVGO's 1747.95%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
51.11%
Below 50% of AVGO's 129.36%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
87.03%
3Y net income/share CAGR 50-75% of AVGO's 140.48%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
266.85%
10Y equity/share CAGR at 50-75% of AVGO's 368.60%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
70.01%
Below 50% of AVGO's 174.64%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.74%
Below 50% of AVGO's 73.69%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-15.87%
Firm’s AR is declining while AVGO shows 25.96%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
18.33%
Inventory growth well above AVGO's 3.35%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
4.58%
Asset growth at 75-90% of AVGO's 6.05%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
5.77%
Similar to AVGO's 5.73%. Walter Schloss finds parallel capital usage or profit distribution strategies.
0.44%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.40%
R&D growth drastically higher vs. AVGO's 3.99%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.50%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.